Cellectar Biosciences, Inc. (CLRB) vs Lisata Therapeutics, Inc. (LSTA)
A side-by-side comparison of Cellectar Biosciences, Inc. and Lisata Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
CLRB
Cellectar Biosciences, Inc.
$1.60HealthcareDelayed quote: Oct 6, 2026, 12:54 PM EDT
LSTA
Lisata Therapeutics, Inc.
$1.17HealthcareDelayed quote: Oct 6, 2026, 12:52 PM EDT
Total return — CLRB vs LSTA
growth of $100 · dividends reinvested · last 10yCLRB -100.0% (-55.5%/yr)LSTA -98.2% (-32.9%/yr)LSTA compounded faster over this window
Log scale — wide-divergence pair
CLRB LSTA
CLRB vs LSTA: by the numbers
- •CLRB is the larger company ($13M vs $11M market cap).
- •Both run net losses; CLRB's is the smaller (0.00% vs -14621.00% net margin).
Metrics side by side
Valuation
| Metric | CLRB | LSTA |
|---|---|---|
| P/S ratio | N/A | 106.54 |
| P/B ratio | 0.43 | 1.29 |
Profitability
| Metric | CLRB | LSTA |
|---|---|---|
| Gross margin | 0.00% | 14.12% |
| Operating margin | 0.00% | -10711.18% |
| Net margin | 0.00% | -14621.00% |
| ROE | -74.73% | -177.35% |
| ROIC | -74.94% | -204.32% |
Growth (annualized)
| Metric | CLRB | LSTA |
|---|---|---|
| Total return CAGR (5Y) | -60.51% | -40.75% |
Frequently asked
- How have CLRB and LSTA total returns compared?
- Over the past 10 years, CLRB delivered -55.35% and LSTA delivered -32.84% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.